Literature DB >> 11137452

Regulation of death receptor-mediated apoptosis pathways.

I Schmitz1, S Kirchhoff, P H Krammer.   

Abstract

Apoptosis or programmed cell death can be induced by a variety of stimuli including activation of death receptors. This subgroup of the TNF/NGF-receptor-superfamily activates caspases, a family of aspartyl-specific cysteine-proteases, which are the main executioners of apoptosis. Depending on the cell type, signalling pathways downstream of the death receptors can be modulated by different proteins such as Bcl-2, FLIPs, chaperones and kinases. Deregulation of apoptosis has been associated with diseases as cancer, autoimmunity and AIDS. Therefore, the identification of modulators of apoptosis has several therapeutic implications.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11137452     DOI: 10.1016/s1357-2725(00)00048-0

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  59 in total

Review 1.  FLICE-inhibitory proteins: regulators of death receptor-mediated apoptosis.

Authors:  A Krueger; S Baumann; P H Krammer; S Kirchhoff
Journal:  Mol Cell Biol       Date:  2001-12       Impact factor: 4.272

Review 2.  Molecular mechanisms of irradiation-induced apoptosis.

Authors:  Lei Zhou; Rong Yuan; Lanata Serggio
Journal:  Front Biosci       Date:  2003-01-01

3.  Localization of sequences in a protein (ORF2) encoded by the latency-related gene of bovine herpesvirus 1 that inhibits apoptosis and interferes with Notch1-mediated trans-activation of the bICP0 promoter.

Authors:  Devis Sinani; Clinton Jones
Journal:  J Virol       Date:  2011-09-21       Impact factor: 5.103

4.  Introducing point mutations into the ATGs of the putative open reading frames of the HSV-1 gene encoding the latency associated transcript (LAT) reduces its anti-apoptosis activity.

Authors:  Dale Carpenter; Gail Henderson; Chinhui Hsiang; Nelson Osorio; Lbachir BenMohamed; Clinton Jones; Steven L Wechsler
Journal:  Microb Pathog       Date:  2007-08-12       Impact factor: 3.738

Review 5.  Immune surveillance in melanoma: From immune attack to melanoma escape and even counterattack.

Authors:  Fade Mahmoud; Bradley Shields; Issam Makhoul; Nathan Avaritt; Henry K Wong; Laura F Hutchins; Sara Shalin; Alan J Tackett
Journal:  Cancer Biol Ther       Date:  2017-05-17       Impact factor: 4.742

6.  Oridonin induces apoptosis in gastric cancer through Apaf-1, cytochrome c and caspase-3 signaling pathway.

Authors:  Ke-Wang Sun; Ying-Yu Ma; Tian-Pei Guan; Ying-Jie Xia; Chang-Ming Shao; Le-Gao Chen; Ya-Jun Ren; Hai-Bo Yao; Qiong Yang; Xu-Jun He
Journal:  World J Gastroenterol       Date:  2012-12-28       Impact factor: 5.742

7.  The gene that encodes the herpes simplex virus type 1 latency-associated transcript influences the accumulation of transcripts (Bcl-x(L) and Bcl-x(S)) that encode apoptotic regulatory proteins.

Authors:  Weiping Peng; Gail Henderson; Guey-Chuen Perng; Anthony B Nesburn; Steven L Wechsler; Clinton Jones
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

8.  Herpes simplex virus type 1 latency-associated transcript inhibits apoptosis and promotes neurite sprouting in neuroblastoma cells following serum starvation by maintaining protein kinase B (AKT) levels.

Authors:  Sumin Li; Dale Carpenter; Chinhui Hsiang; Steven L Wechsler; Clinton Jones
Journal:  J Gen Virol       Date:  2009-12-02       Impact factor: 3.891

Review 9.  MAC and Bcl-2 family proteins conspire in a deadly plot.

Authors:  Laurent M Dejean; Shin-Young Ryu; Sonia Martinez-Caballero; Oscar Teijido; Pablo M Peixoto; Kathleen W Kinnally
Journal:  Biochim Biophys Acta       Date:  2010-01-18

10.  Cellular FLIP can substitute for the herpes simplex virus type 1 latency-associated transcript gene to support a wild-type virus reactivation phenotype in mice.

Authors:  Ling Jin; Dale Carpenter; Megan Moerdyk-Schauwecker; Adam L Vanarsdall; Nelson Osorio; Chinhui Hsiang; Clinton Jones; Steven L Wechsler
Journal:  J Neurovirol       Date:  2008-11-12       Impact factor: 2.643

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.